Professor of Psychiatry, University Mich Medical School
Psychiatry
Dr. Alan M. Mellow, MD
|
|
Give Review
Doctor Alan M. Mellow, MD works in the field of Psychiatry. He graduated from Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19/29 in Research/PrimaryCare. He has 2 awards "America's Top Doctors" and "CMS Meaningful Use Stage 1 Certification". Alan Mellow is also published. He has 62 publications published. The lastest publication: "Psychiatric diagnosis and intervention in older and younger patients in a primary care clinic: effect of a screening and diagnostic instrument.' He is registered with Medicare and accepts Medicare payments.
Publications
- Quality improvement toward decreasing high-risk medications for older veteran outpatients.
- Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample.
- Race and depression: does race affect the diagnosis and treatment of late-life depression?
- Race, gender, and psychiatrists' diagnosis and treatment of Major depression among elderly patients.
- Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression.
- Effect of race and sex on primary care physicians' diagnosis and treatment of late-life depression.
- Cerebrovascular disease and late-life depression.
- Herbal products and other supplements: use by elderly veterans with depression and dementia and their caregivers.
- Antidepressant use by race.
- Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.
- Race, psychiatric diagnosis, and Mental health care utilization in older patients.
- Serotonin dysregulation in adolescents with Major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion.
- Race and inpatient psychiatric diagnoses among elderly veterans.
- Ileus as a possible result of bupropion in an elderly woman.
- The efficacy, safety, and tolerability of antipsychotics in the elderly.
- Health care utilization by older patients with coexisting dementia and depression.
- Psychiatric diagnosis and intervention in older and younger patients in a primary care clinic: effect of a screening and diagnostic instrument.
- Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
- Cognitive, behavioral, and motor effects of the NMDA antagonist ketamine in Huntington's disease.
- Management of treatment resistance in the depressed geriatric patient.
- A peptide enhancement strategy in Alzheimer's disease: pilot study with TRH-physostigmine infusions.
- Sodium valproate in the treatment of behavioral disturbance in dementia.
- CSF somatostatin in Alzheimer''s disease and Major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
- Depression during hormonal treatment of prostate cancer.
- High-dose selegiline in treatment-resistant older Depressive patients.
- Effects of calcium and strontium in the process of acetylcholine release from motor nerve endings.
- Intracellular magnesium does not antagonize calcium-dependent acetylcholine secretion.
- A new scale for the assessment of depressed Mood in demented patients.
- Thyroid disease and dementia of the Alzheimer type.
- A pilot study of serotonergic system responsivity in Alzheimer's disease.
- Intravenous nicotine in Alzheimer''s disease: a pilot study.
- Central muscarinic cholinergic antagonists block wet-dog shakes produced by the TRH analog MK-771 in the rat.
- L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition.
- Thyrotropin-releasing hormone and dementia.
- The effects of acute scopolamine in geriatric depression.
- A preliminary study of the effects of intravenous m-chlorophenylpiperazine, a serotonin agonist, in elderly subjects.
- CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.
- Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects.
- Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
- Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study.
- Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer''s disease.
- Galanin immunoreactivity in human CSF: studies in eating Disorders and Alzheimer''s disease.
- Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer''s disease.
- Automatic memory processes in patients with dementia-Alzheimer''s type (DAT).
- Effects of daily oral m-chlorophenylpiperazine in elderly depressed patients. Initial experience with a serotonin agonist.
- TRH attenuates scopolamine-induced memory impairment in humans.
- A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers.
- Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer''s disease.
- The TRH stimulation test in Alzheimer's disease and Major depression: relationship to clinical and CSF measures.
- A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease.
- CSF monoamine metabolites and somatostatin in Alzheimer's disease and Major depression.
- The dexamethasone suppression test in Alzheimer's disease and Major depression: relationship to dementia severity, depression, and CSF monoamines.
- Characterization of two distinct 5-HT receptors coupled to adenylate cyclase activation and ion current generation in NCB-20 cells.
- Antidepressant treatment of pathologic laughing or crying in elderly stroke patients.
- A strategy of "combination chemotherapy" in Alzheimer's disease: rationale and preliminary results with physostigmine plus deprenyl.
- On the conductance pathway traversed by strontium in mediating the asynchronous release of acetylcholine by motor nerve impulses.
- Conventional calcium channel mediates asynchronous acetylcholine release by motor nerve impulses.
- Dissociation of specific binding of 25-OH-D3 and resorption in fetal rat bones.
- Equivalence of Ca2+ and Sr2+ in transmitter release from K+-depolarised nerve terminals.
- Depression in veterans with Parkinson''s disease: frequency, co-morbidity, and healthcare utilization.
- The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers.
Schools
Northwestern Center Feinberg School of Medicine
McLean HospHarvard Med School
University Chicago Hospital
Nimh
Procedures Preformed
- Family Psychotherapy
- Psychiatric Evaluation
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Adjustment Disorder
- Alcoholism (Alcohol Dependence)
- Anxiety
- Attention Deficit Hyperactivity Disorder (ADHD)
- View All
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
University of Chicago -
Northwestern University Feinberg School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1790861714 | |
| NPPES Provider LastName | MELLOW | |
| NPPES Provider FirstName | ALAN | |
| NPPES Provider ZIPCode | 481092700 | |
| NPPES Provider State | MI | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 221.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790861714 |
| Last Name Of The Provider | MELLOW |
| First Name Of The Provider | ALAN |
| View All |
Similar Doctors
|
|
Dr. Lauren T. Edwards, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Helen C. Kales, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald M. Benson, MD |
|
|
Dr. Mohammad Ghaziuddin, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anne Eisen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward R. MacPhee III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David G. Beltzman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lewis P. Krain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sekhar C. Sripada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Israel Liberzon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert G. Drake Jr., MD |
|
|
Dr. Lubna Z. Grewal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elise C. Forrest, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arash Javanbakht, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vasilis K. Pozios, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Iquo O. Nafiu, MB BS
This Doctor is OpenDoctor Recommended.
|